First, a disclaimer: No market map is fully exhaustive.
We focused our efforts on the companies deploying AI agents in the ambulatory or outpatient setting. These companies are generally also post-series A, as there has been an explosion of pre-seed and seed activity in the space. We also excluded vendors whose primary business model is selling into healthcare systems. Submissions came from a cross section of our network, inclusive of venture capital investors, operators, and founders (see the full list that contributed directly underneath the map).

To be fully transparent, we struggled a bit in the scribe category because, in some cases, the agents involve a roadmapping exercise, while others are live.
If your company fits the criteria and should be on the list, reach out to us before our next update!
Reserve Your Spot for Upcoming Webinars!
Webinar Topic | Panelists’ | Timing | Registration |
|---|---|---|---|
Privacy AI and the future of HIPAA with the former founding director of ONC | Jodi Daniel, Christina Farr | June 3rd, 2026 | |
Not everyone can access the Top 1% of physicians. Will AI change that? | Daniel Stein | June 18th, 2026 |
Want to support Second Opinion?
🌟 Leave a review for the Second Opinion Podcast
📧 Share this email with other friends in the healthcare space!
💵 Become a paid subscriber!
📢 Become a sponsor
Want more? Second Opinion Premium goes further.
Second Opinion Premium membership gives you even more depth, with exclusive reporting, member-only insights, and practical tools you can put to work.
Upgrade to PremiumPremium membership unlocks:
- Exclusive deep dives and strategic perspectives
- Market maps, guides, and frameworks
- Members-only webinars and events
- Exclusive reports and evidence-backed analysis




